Inefficient protection of human TAP-deficient fibroblasts from autologous NK cell-mediated lysis by cytokines inducing HLA class I expression

European Journal of Immunology

Volumn 29, Issue 4, 1999, Pages 1286-1291

  Zimmer, Jacques ^a   Donato, Lionel ^b   Hanau, Daniel ^a   Cazenave, Jean Pierre ^a   Moretta, Alessandro ^c   Tongio, Marie Marthe ^a   De La Salle, Henri ^a  

^a INSERM   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Cytokine; Fibroblast; HLA class I; NK cell; TAP deficiency

Indexed keywords

ALPHA INTERFERON; CARRIER PROTEIN; CYTOKINE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

EID: 0032910215     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199904)29:04<1286::AID-IMMU1286>3.0.CO;2-L     Document Type: Article

References (15)

1. de la Salle, H., Hanau, D., Fricker, D., Urlacher, A., Kelly, A., Salamero, J., Powis, H., Donato, L, Bausinger, H., Laforet, M., Jeras, M., Spehner, D., Bieber, T., Falkenrodt, A., Cazenave, J. P., Trowsdale, H. and Tongio, M. M., Homozygous human TAP peptide transporter mutation in HLA class I deficiency. Science 1994. 265: 237-241.
2. Donato, L., de la Salle, H., Hanau, D., Tongio, M. M., Oswald, M., Vandevenne, A. and Geisert, J., Association of HLA class I antigen deficiency related to a TAP-2 gene mutation with familial bronchiectasis. J. Pediatr. 1995. 127: 895-900.
3. Trinchieri, G., The biology of natural killer cells. Adv. Immunol. 1989. 47: 187-376.
4. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C. and Moretta, L., Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 1997. 155: 105-117.
5. Zimmer, J., Donato, L., Hanau, D., Cazenave, J. P., Tongio, M. M., Moretta, A. and de la Salle, H., Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J. Exp. Med. 1998. 187: 117-122.
6. Zambello, R., Trentin, L., Enthammer, C., Cipriani, A., Agostini, C. and Semenzato, G., Lysis of pulmonary fibroblasts by lymphokine (IL-2)-activated killer cells - a mechanism affecting the human lung environment? Clin. Exp. Immunol. 1996. 105: 383-388.
7. Trinchieri, G., Granato, D. and Perussia, B., Interferoninduced resistance of fibroblasts to cytolysis mediated by natural killer cells: specificity and mechanism. J. Immunol. 1981. 126: 335-340.
8. Canessa, A., Chatterjee, S., Whitley, R., Prasthofer, E. F, Grossi, C. E. and Tilden, A. B., Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon. Viral Immunol. 1990. 3: 217-224.
9. Hamprecht, K. and Steinmassl, M., Low-dose human cytomegalovirus infection of human fibroblast cultures induces lymphokine-activated killer cell resistance: interferon-β-mediated target cell protection does not correlate with up-regulation of HLA class I surface molecules. Immunology 1994. 852: 171-177.
10. Ayalon, O., Hughes, E. A., Cresswell, P., Lee, J., O'Donnell, L., Pardi, R. and Bender, J. R., Induction of transporter associated with antigen processing by interferon γ confers endothelial cell cytoprotection against natural killer-mediated lysis. Proc. Natl. Acad. Sci. USA 1998. 95: 2435-2440.
11. Grönberg, A., Ferm, M., Tsai, L. and Kiessling, R., Interferon is able to reduce tumor cell susceptibility to human lymphokine-activated killer (LAK) cells. Cell. Immunol. 1989. 118: 10-21.
12. Reiter, Z. and Rappaport, B., Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Crit. Rev. Immunol. 1993. 13: 1-34.
13. Ciccone, E., Pende, D., Vitale, M., Nanni, L., Di Donate, C., Bottino, C., Morelli, L., Viale, O., Amoroso, A., Moretta, A. and Moretta, L., Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur. J. Immunol. 1994. 24: 1003-1006.
14. de la Salle, H., Zimmer, J., Fricker, D., Angenieux, C., Cazenave, J. P., Okubo, M., Maeda, H., Plebani, A., Tongio, M. M., Dormoy, A. and Hanau, D., HLA class I deficiencies due to mutations in the subunit 1 of the peptide transporter (TAP1). J. Clin. Invest, in press.
15. Teisserenc, H., Schmitt, W., Blake, N., Dunbar, R., Gadola, S., Gross, W. L., Exley, A. and Cerundolo, V., A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway. Immunol. Lett. 1997. 57: 183-187.